Individualising CML Therapy to Facilitate Successful Treatment Free Remission

该项目将确定慢性髓性白血病（CML）患者的最佳治疗方案，根据每个患者独特的生物学特征，为每个患者匹配最合适的药物，从而最大限度地提高治愈的机会。此外，该项目将开发新的高度敏感的检测方法，以检测残留疾病的存在，即使目前的技术无法检测到。这将使关键的、及时的治疗改变能够以治疗为目的。

This project will determine the optimal therapy for patients with chronic myeloid leukaemia (CML), matching the most appropriate drug to the individual patient, based on each patient's unique biology, thereby maximising the chance of cure. Furthermore, this project will develop novel highly sensitive tests for the presence of residual disease, even if undetectable by current techniques. This will enable crucial, timely treatment changes to be made with curative intent.